Retraction Note: Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling

Affiliations

¹ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Horus University, New Damietta, Egypt.
² Medical Experimental Research Center (MERC), Faculty of Medicine, Mansoura University, Mansoura, Egypt.
³ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt.
⁴ Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt.
⁵ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt. samar_saad_azab@pharma.asu.edu.eg.

Mennatallah O Zaki et al. Inflammopharmacology. 2025 Sep.

. 2025 Sep;33(9):5637.

doi: 10.1007/s10787-025-01819-6.

¹ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Horus University, New Damietta, Egypt.
² Medical Experimental Research Center (MERC), Faculty of Medicine, Mansoura University, Mansoura, Egypt.
³ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt.
⁴ Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt.
⁵ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt. samar_saad_azab@pharma.asu.edu.eg.

No abstract available

Retraction of

Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling.
Zaki MO, El-Desouky S, Elsherbiny DA, Salama M, Azab SS. Zaki MO, et al. Inflammopharmacology. 2022 Oct;30(5):1871-1890. doi: 10.1007/s10787-022-01023-w. Epub 2022 Aug 3. Inflammopharmacology. 2022. Retraction in: Inflammopharmacology. 2025 Sep;33(9):5637. doi: 10.1007/s10787-025-01819-6. PMID: 35922737 Free PMC article. Retracted.